2026³â01¿ù01ÀÏthu
·Î±×ÀÎ | ȸ¿ø°¡ÀÔ
OFF
Æ®À§ÅÍ·Î º¸³»±â ½ÎÀÌ¿ùµå °ø°¨
±â»ç±ÛÈ®´ë ±â»ç±ÛÃà¼Ò ±â»ç½ºÅ©·¦ À̸ÞÀϹ®ÀÇ ÇÁ¸°Æ®Çϱâ
ÇѾç´ëº´¿ø, ³»´Þ 6ÀÏ ¡®Á¦5ȸ ¾Ï¼¾ÅÍ ½ÉÆ÷Áö¾ö¡¯
[ 2018³â 09¿ù 30ÀÏ 18½Ã 40ºÐ ]
[µ¥Àϸ®¸Þµð °íÀç¿ì ±âÀÚ] ÇѾç´ëº´¿øÀº 10¿ù6ÀÏ Àǰú´ëÇÐ º»°ü 6Ãþ TBL½Ç¿¡¼­ 'Á¦5ȸ ¾Ï¼¾ÅÍ ½ÉÆ÷Áö¾ö'À» °³ÃÖÇÑ´Ù°í 30ÀÏ ¹àÇû´Ù.
 
½ÉÆ÷Áö¾öÀº ÃÑ3°³ÀÇ ¼¼¼ÇÀ¸·Î ±¸¼ºµÆ´Ù. ù ¹øÂ° ¼¼¼ÇÀº ÇѾç´ëº´¿ø ±Ç¼ºÁØ ±³¼ö(¿Ü°ú)¿Í ±èµ¿¼± ±³¼ö(³»ºÐºñ´ë»ç³»°ú)°¡ ÁÂÀåÀ» ¸Ã°í, ¼Û¿µ¼ö ±³¼ö(º´¸®°ú)°¡ ‘Bioinfomatics & NGS’, ±è¿©Àº ±³¼ö(Áø´Ü°Ë»çÀÇÇаú°¡ ‘Hereditary cancer syndrome’. ½Å¼öÁø º´¸®°ú ±³¼ö°¡ ‘Clinical application of NGS’ µîÀ» ÁÖÁ¦·Î °­¿¬ÇÑ´Ù.
 
µÎ ¹øÂ° ¼¼¼ÇÀº Á¤¿ø»ó ±³¼ö(ÈäºÎ¿Ü°ú)¿Í ÀÌ¿µÈ£ ±³¼ö(¼Ò¾ÆÃ»¼Ò³â°ú)°¡ ÁÂÀåÀ» ¸Ã°í, ¹éÁ¤Èì °¡Ãµ´ë ±æº´¿ø ±³¼ö°¡ ‘MDT with Watson for Oncology in Solid Tumor’, ¾çÇöÁø ¹Ú»ç(¢ß½ÅÅ×Ä«¹ÙÀÌ¿À)°¡ ‘Leveraging genomic data and AI in precision medicine’, ÀÌÀ¯¶ó ¼­¿ï¾Æ»êº´¿ø ±³¼ö°¡ ‘Information technology for predictive, preventive, personalized and participatory medicine’ µîÀ» ÁÖÁ¦·Î ¹ßÇ¥ÇÑ´Ù.
 
¼¼ ¹øÂ° ¼¼¼Ç¿¡¼­´Â ÃÖÈ£¼ø ±³¼ö(¼ÒÈ­±â³»°ú)°¡ ÁÂÀåÀ» ¸Ã°í, À±ÀçÈÆ ±³¼ö(¼ÒÈ­±â³»°ú)°¡ ‘chemotherapy’, ¹ÚÇýÁø ±³¼ö(¹æ»ç¼±Á¾¾çÇаú)°¡ ‘Radiotherapy’ µî¿¡ ´ëÇØ °­¿¬À» ÆîÄ£´Ù.
ko@dailymedi.com
À̱âÀÚÀÇ ´Ù¸¥´º½ºº¸±â
¹«ÅëÀåÀÔ±Ý Á¤º¸ÀÔ·Â ÀÔ±ÝÀÚ¸í ÀԱݿ¹Á¤ÀÏÀÚ
(ÀÔ±ÝÇÏ½Ç ÀÔ±ÝÀÚ¸í + ÀԱݿ¹Á¤ÀÏÀÚ¸¦ ÀÔ·ÂÇϼ¼¿ä)
[°ü·Ã´º½º]
- °ü·Ã´º½º°¡ ¾ø½À´Ï´Ù.
Æ®À§ÅÍ·Î º¸³»±â ½ÎÀÌ¿ùµå °ø°¨
±â»ç±ÛÈ®´ë ±â»ç±ÛÃà¼Ò ±â»ç½ºÅ©·¦ À̸ÞÀϹ®ÀÇ ÇÁ¸°Æ®Çϱâ
¸íÁöº´¿ø, ͺ À̰ÇÈñ ȸÀå ÁÖÄ¡ÀÇ À̰­¿ì ±³¼ö(»ï¼º¼­¿ïº´¿ø ÀçȰÀÇÇаú) ¿µÀÔ
´ëÀü¼º¸ðº´¿ø ±èµ¿±â¡¤À̵¿Ã¢ ±³¼ö, ´ëÇÑÀ̺ñÀÎÈİúÇÐȸ ÃÖ¿ì¼ö ±¸¿¬»ó¡¤ÃÖ¿ì¼ö Æ÷½ºÅÍ»ó
Á¶Àç¿ì ±³¼ö(°í´ë±¸·Îº´¿ø Á¤Çü¿Ü°ú), ´ëÇѰñÀýÇÐȸ ÃÖ´Ù³í¹®»ó
´ëÇÑÀÇ»çÇùȸ ºÎȸÀå ¹éÇö¿í¡¤Àǹ«ÀÌ»ç ¿Àµ¿È£¡¤Á¤º¸Åë½ÅÀÌ»ç À¯¼Ò¿µèâ
Çѱ¹Á¦¾à¹ÙÀÌ¿ÀÇùȸ ÀǾàǰ±¤°í½ÉÀÇÀ§¿øÈ¸ À§¿øÀå ±è¼ºÁø¡¤ºÎÀ§¿øÀå ÀÌÁØÈñ¡¤ÀåÃá°ï èâ
¹è±â¼ö ±³¼ö(¾ÆÁִ뺴¿ø ¼Ò¾ÆÃ»¼Ò³â°ú), Á¦100ȸ ¾î¸°À̳¯ ¿ÁÁ¶±ÙÁ¤ÈÆÀå
À̺´ÈÆ¡¤½ÉÀç¾Ó ±³¼öÆÀ(±æº´¿ø Á¤Çü¿Ü°ú), ´ëÇѰñÀýÇÐȸ ¿ÃÇØ ¿ì¼ö ±¸¿¬»ó
³²°¡Àº ±³¼ö(°í´ë±¸·Îº´¿ø °¡Á¤ÀÇÇаú), Çѱ¹¿©ÀÚÀÇ»çȸ Á¦4ȸ ÀþÀºÀÇÇÐÀÚ Çмú»ó
±¹¸³Áß¾ÓÀÇ·á¿ø Áß¾ÓÀÀ±ÞÀÇ·á¼¾ÅÍÀå ±è¼ºÁß(Á¶¼±´ëº´¿ø ÀÀ±ÞÀÇÇаú ±³¼ö)
ÃÖÁ¤¿õ ¿µ°æÀÇ·áÀç´Ü ÀüÁÖº´¿ø ÀÌ»çÀå, ¾Æµ¿º¸È£»ç¾÷ ±â±Ý 4000¸¸¿ø
±è¿µÁÖ ±³¼ö(ÀÌ´ë¸ñµ¿º´¿ø »êºÎÀΰú), Á¦13ȸ Çѵ¶¿©ÀÇ»çÇмú´ë»ó
¹ÚÂùÈì ±³¼ö(ÇѸ²´ëÃáõ¼º½Éº´¿ø À̺ñÀÎÈİú), ´ëÇÑÀ̺ñÀÎÈİúÇÐȸ Çмú»ó
Á¶¼öÁø ±³¼ö(ÇѸ²´ëµ¿Åº¼º½Éº´¿ø ½Å°æ°ú), Á¦26ȸ JWÁß¿ÜÇмú´ë»ó
¼­Á¤°Ç ¿¬¼¼¼­³»°ú ¿øÀå ÀåÀλó